ACTA1 and pulmonary fibrosis: identified that EW-7197, a novel small molecule inhibitor of TGF-β type I receptor kinase (ALK5), can inhibit pulmonary fibrosis by blocking the TGF-β/Smad signaling pathway and can decrease the expression of collagen, α-SMA, and fibronectin in mice (31).